Vaxart, Inc. (VXRT)
0.486
-0.01
(-2.78%)
USD |
OTCM |
Sep 18, 16:00
Vaxart Price : 0.486 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 0.4809 | 0.49 | 0.48 | 0.486 | 148314.0 |
| Sep 17, 2026 | 0.47 | 0.50 | 0.465 | 0.4999 | 324960.0 |
| Sep 16, 2026 | 0.48 | 0.48 | 0.4501 | 0.474 | 247761.0 |
| Sep 15, 2026 | 0.4999 | 0.4999 | 0.45 | 0.48 | 617116.0 |
| Sep 14, 2026 | 0.50 | 0.52 | 0.4801 | 0.49 | 264872.0 |
| Sep 11, 2026 | 0.475 | 0.50 | 0.475 | 0.485 | 45290.00 |
| Sep 10, 2026 | 0.485 | 0.4987 | 0.4661 | 0.4870 | 198347.0 |
| Sep 09, 2026 | 0.49 | 0.5074 | 0.475 | 0.4884 | 272002.0 |
| Sep 08, 2026 | 0.4931 | 0.51 | 0.49 | 0.5037 | 293414.0 |
| Sep 04, 2026 | 0.50 | 0.51 | 0.4903 | 0.495 | 130592.0 |
| Sep 03, 2026 | 0.495 | 0.52 | 0.4902 | 0.4925 | 256912.0 |
| Sep 02, 2026 | 0.495 | 0.5095 | 0.49 | 0.4905 | 252589.0 |
| Sep 01, 2026 | 0.51 | 0.5189 | 0.49 | 0.493 | 262462.0 |
| Aug 31, 2026 | 0.5052 | 0.52 | 0.5005 | 0.51 | 221455.0 |
| Aug 28, 2026 | 0.504 | 0.5083 | 0.4901 | 0.5016 | 227645.0 |
| Aug 27, 2026 | 0.5022 | 0.5097 | 0.4901 | 0.5033 | 554436.0 |
| Aug 26, 2026 | 0.51 | 0.5206 | 0.50 | 0.5045 | 208088.0 |
| Aug 25, 2026 | 0.4901 | 0.5295 | 0.4901 | 0.5025 | 238924.0 |
| Aug 24, 2026 | 0.5395 | 0.56 | 0.4996 | 0.5005 | 363825.0 |
| Aug 21, 2026 | 0.52 | 0.55 | 0.4949 | 0.515 | 358873.0 |
| Aug 20, 2026 | 0.512 | 0.5262 | 0.50 | 0.5197 | 299005.0 |
| Aug 19, 2026 | 0.4804 | 0.5436 | 0.4608 | 0.4978 | 358609.0 |
| Aug 18, 2026 | 0.504 | 0.5195 | 0.4904 | 0.4951 | 162097.0 |
| Aug 17, 2026 | 0.54 | 0.5675 | 0.4705 | 0.494 | 547262.0 |
| Aug 14, 2026 | 0.56 | 0.5695 | 0.5431 | 0.5435 | 137763.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.85 |
| Amgen, Inc. | 385.65 |
| Anika Therapeutics, Inc. | 20.81 |
| BioCryst Pharmaceuticals, Inc. | 8.68 |
| Imunon, Inc. | 1.36 |
Price Related Metrics
| PE Ratio | 3.057 |
| PS Ratio | 0.4768 |
| Price to Book Value | 1.433 |
| Price to Free Cash Flow | 3.472 |
| Earnings Yield | 32.72% |
| Market Cap | 118.02M |
| Operating PE Ratio | 2.925 |
| Normalized PE Ratio | 3.057 |